Keros Therapeutics (KROS) Prepaid Assets (2019 - 2025)
Keros Therapeutics (KROS) reported Prepaid Assets of $2.4 million for Q4 2025, down 90.86% on a YoY basis from $26.2 million in Q4 2024, and down 89.27% quarter-over-quarter from $22.3 million in Q3 2025.
Keros Therapeutics (KROS) Prepaid Assets (2019 - 2025) Analysis & Trends
Keros Therapeutics has reported Prepaid Assets for 7 years, with the latest figure at $2.4 million in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets fell 90.86% year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (down 90.86% YoY), and the FY2025 full-year result was $2.4 million, down 90.86% from the prior year.
- Prepaid Assets for Q4 2025 stood at $2.4 million, down from $22.3 million in the prior quarter.
- The five-year high for Prepaid Assets was $26.8 million in Q2 2024, with the low at $210000.0 in Q4 2021.
- Historically, Prepaid Assets has averaged $9.8 million across 5 years, with a median of $6.7 million in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 4200.0% — and 2025, when it sank 90.86%.
- Keros Therapeutics' Prepaid Assets stood at $210000.0 in 2021, then surged by 3099.52% to $6.7 million in 2022, then surged by 138.18% to $16.0 million in 2023, then jumped by 63.84% to $26.2 million in 2024, then slumped by 90.86% to $2.4 million in 2025.
- The last three Prepaid Assets figures came in at $2.4 million (Q4 2025), $22.3 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Keros Therapeutics | 399.01 Mn | 111.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 22.34 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 26.22 Mn |
| Sep 30, 2024 | 20.97 Mn |
| Jun 30, 2024 | 26.85 Mn |
| Mar 31, 2024 | 20.46 Mn |
| Dec 31, 2023 | 16.00 Mn |
| Sep 30, 2023 | 16.54 Mn |
| Jun 30, 2023 | 12.28 Mn |
| Mar 31, 2023 | 10.79 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Sep 30, 2022 | 745,000.00 |
| Jun 30, 2022 | 6.74 Mn |
| Mar 31, 2022 | 251,000.00 |
| Dec 31, 2021 | 210,000.00 |
| Sep 30, 2021 | 313,000.00 |
| Jun 30, 2021 | 290,000.00 |
| Mar 31, 2021 | 265,000.00 |